Haemonetics (HAE) Non-Current Debt (2010 - 2026)

Haemonetics has reported Non-Current Debt for 17 years, with the latest figure at $1.2 billion in Q2 2026.

• On a quarterly basis, Non-Current Debt fell 2.99% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 2.99% decrease from a year earlier, with the FY2026 full-year figure at $1.2 billion, up 32.38% from the prior year.
• Non-Current Debt was $1.2 billion for Q2 2026 at Haemonetics, down from $1.2 billion in the prior quarter.
• The five-year high for Non-Current Debt was $1.2 billion in Q2 2025, with the low at $559.4 million in Q2 2022.
• Average Non-Current Debt over 5 years is $949.6 million, with a median of $856.8 million recorded in 2023.
• The largest YoY upside for Non-Current Debt was 116.29% in 2022 against a maximum downside of 18.99% in 2022.
• Over 5 years, Non-Current Debt stood at $756.8 million in 2022, then rose by 13.22% to $856.8 million in 2023, then surged by 42.35% to $1.2 billion in 2024, then advanced by 0.41% to $1.2 billion in 2025, then retreated by 2.98% to $1.2 billion in 2026.
• The last three Non-Current Debt figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.